The mechanism behind these effects was hypothesized to involve CD200:CD200R-mediated regulation of the expression of chemokines in tumor-associated myeloid cells, which, in the absence of CD200R engagement, produced CCL24 with the increased infiltration of eosinophils, contributing to anti-tumor activity. The gene discussed is CD200R1; the disease is neoplasm.